Table 4.

Follow-up of patients in this study

Patient no.a	Follow-up term (months)	No. of TACE sessions	No. of regimen changes	Dead/Alive	Reason of death
1	23	13	1	Dead	Progression of lung metastasis
2	40	8	3	Dead	Progression of lung metastasis
3	9	6	3	Dead	Unknown
4	11	2	0	Dead	Progression of lung metastasis
5	15	4	0	Dead	Progression of brain metastasis
6	1	2	0	Dead	Unknown
7	48	7	2	Alive	−
8	34	3	1	Dead	Pneumonia
9	1	1	-	Unknown	-
10	12	9	1	Dead	Progression of primary HCC
11	2	3	0	Unknown	−
12	2	1	-	Unknown	−
13	100	5	0	Alive	−
14	1	2	1	Unknown	−

HCC, hepatocellular carcinoma.

^aPatient numbers do not match those of Figure 4.